paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
pharmox cv 500 mg/1 bočica+ 100 mg/1 bočica prašak za rastvor za injekciju/infuziju
doo ˝farmacija 2011˝ bihać - amoksicilin, klavulanska kiselina - prašak za rastvor za injekciju/infuziju - 500 mg/1 bočica+ 100 mg/1 bočica - 1 bočica sadrži: sterilni amoksicilinnatrij bp ekvivalentno amoksicilinu 500 mg i sterilni klavulanatkalij usp ekvivalentno klavulanskoj kiselini 100 mg
pharmox cv 1000 mg/1 bočica+ 200 mg/1 bočica prašak za rastvor za injekciju/infuziju
doo ˝farmacija 2011˝ bihać - amoksicilin, klavulanska kiselina - prašak za rastvor za injekciju/infuziju - 1000 mg/1 bočica+ 200 mg/1 bočica - 1 bočica sadrži: sterilni amoksicilinnatrij bp ekvivalentno amoksicilinu 1000 mg i sterilni klavulanatkalij usp ekvivalentno klavulanskoj kiselini 200 mg
zacef 1 g/1 bočica prašak za rastvor za injekciju
doo ˝farmacija 2011˝ bihać - ceftazidim - prašak za rastvor za injekciju - 1 g/1 bočica - 1 bočica sadrži 1 g ceftazidima (u obliku pentahidrata) sa natrijumkarbonatom (118 mg po gramu ceftazidima).
vankar 1000 1000 mg/1 bočica prašak za rastvor za infuziju
doo ˝farmacija 2011˝ bihać - vankomicin - prašak za rastvor za infuziju - 1000 mg/1 bočica - 1 bočica sa praškom za rastvor za infuziju sadrži: 1000 mg vankomicin (u obliku vankomicinhidrohlorida) što je ekvivalentno 1 000 000 iu vankomicina
tyenne
fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - imunosupresivi - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.
topamax 50mg film tableta
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - topiramat - film tableta - 50mg
rispolept consta 25mg prašak i rastvarač za suspenziju za injekciju sa produženim oslobađanjem
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - risperidon - prašak i rastvarač za suspenziju za injekciju sa produženim oslobađanjem - 25mg
rispolept consta 37.5mg prašak i rastvarač za suspenziju za injekciju sa produženim oslobađanjem
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - risperidon - prašak i rastvarač za suspenziju za injekciju sa produženim oslobađanjem - 37.5mg